1. Cooper JE. Schizophrenia and allied condition. Med Int 1991; 94: 3917–22
2. Davies L, Drummond M. The economic burden of schizophrenia. Psychiatr Bull 1990; 14: 522–5
3. McGrath J, Saha S, Welham J, et al. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine 2004; 2 [online]. Available from URL: http://www.biomedcentral.com/1741-7015/1742/1713 [Accessed March 2005]
4. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association. Am J Psychiatry 1997; 154 (Suppl.): 1-63
5. National Institute for Clinical Excellence. Guidance on the use of newer (atypical) antipsychotic drugs for the prevention of relapse in patients with schizophrenia 2002 [online]. Available from URL: http://www.nice.orh.uk/ pdf/ [Accessed March 2004]